Neurological Events can Range from Mild Cognitive Impairment

Jun Lee^*
*Correspondence: Jun Lee, Department of Neurology, Sungkyunkwan University, Changwon, South Korea, Email:

Keywords

Neurology • Metabolic • Cognitive • Hyperglycemia

Introduction

Stroke-like syndrome refers to a constellation of clinical symptoms and signs that mimic an acute ischemic stroke but without evidence of vascular occlusion on neuroimaging. These events can be caused by diverse etiologies, including mitochondrial disorders, autoimmune encephalitis, epilepsy, vasculitis, and metabolic disturbances. Stroke-like syndrome can present with focal neurological deficits, altered consciousness, seizures, and other neurological abnormalities. Prompt recognition and differentiation from true strokes are crucial to guide appropriate management and prevent unnecessary interventions. The incidence rates of adverse neurological events vary depending on the underlying cause and population studied. For example, medication-related adverse neurological events can range from mild cognitive impairment and tremors to more severe manifestations such as extrapyramidal symptoms and drug-induced movement disorders. The incidence of these events is influenced by factors such as medication type, dosage, duration of use, and individual susceptibility. Neurological complications can also occur following surgical procedures, with varying incidence rates depending on the type of surgery and patient characteristics [1].

Literature Review

In contrast, adverse neurological events associated with metabolic disturbances, such as hyponatremia or hyperglycemia, may manifest as altered mental status, seizures, or focal neurological deficits. Autoimmune encephalitis and vasculitis can present with a wide range of neurological symptoms, including cognitive impairment, seizures, psychosis, and strokelike episodes. Stroke-like syndrome typically presents with focal neurological deficits that mimic ischemic stroke, such as hemiparesis, aphasia, sensory deficits, and visual disturbances. However, the absence of vascular occlusion on neuroimaging distinguishes stroke-like syndrome from true ischemic strokes. The duration and progression of symptoms in stroke-like syndrome can vary, with some cases exhibiting acute-onset symptoms, while others may have subacute or fluctuating presentations. Seizures and altered mental status may also occur in association with stroke-like syndrome [2].

Description

Diagnosing adverse neurological events and stroke-like syndrome can be challenging due to their diverse etiologies and overlapping clinical features. Comprehensive evaluation, including detailed medical history, physical examination, neuroimaging, laboratory investigations and sometimes specialized tests, is necessary to identify the underlying cause accurately. Collaborative multidisciplinary approaches involving neurologists, radiologists, immunologists, and other specialists are often required to guide diagnosis and appropriate management. Recognizing and understanding the incidence and clinical characteristics of adverse neurological events and stroke-like syndrome is critical for providing optimal patient care. Early recognition and accurate diagnosis enable appropriate interventions, including the discontinuation or adjustment of offending medications, initiation of specific treatments for underlying causes and supportive care to address symptoms and complications. Multidisciplinary care, patient education, and long-term follow-up are essential to address the physical, cognitive, and psychosocial aspects of these conditions and optimize patient outcomes [3].

Understanding the incidence and clinical characteristics of these events is crucial for timely recognition, accurate diagnosis and appropriate management. The diverse etiologies and overlapping features of adverse neurological events and stroke-like syndrome require a comprehensive evaluation involving multiple specialties. Collaborative multidisciplinary approaches, patient-centered care, and long-term follow-up are vital to optimize patient outcomes and improve quality of life. Continued research and vigilance in monitoring adverse neurological events will contribute to enhancing our understanding of these conditions and refining their management strategies. Adverse neurological events encompass a range of conditions and symptoms that can occur as a result of various factors, including medication use, underlying medical conditions, and other environmental or genetic factors. Among these events, stroke-like syndrome represents a distinct subset characterized by transient or permanent neurological deficits resembling a stroke. Understanding the incidence, clinical characteristics, and underlying mechanisms of these adverse neurological events is crucial for accurate diagnosis, appropriate management, and improved patient outcomes. This article aims to review the incidence and clinical characteristics of adverse neurological events, with a specific focus on stroke-like syndrome [4].

These events can be categorized into various subtypes, including but not limited to cognitive impairment, seizures, movement disorders, sensory disturbances, and stroke-like syndrome. Adverse neurological events can occur as a result of medication side effects, toxic exposures, metabolic disturbances, autoimmune disorders, or underlying neurological conditions. The incidence and prevalence of adverse neurological events vary depending on the underlying causes and the population being studied. Some events, such as seizures, have a relatively high incidence in the general population, while others, like stroke-like syndrome, may be rarer and occur in specific clinical contexts. Large-scale epidemiological studies and population-based registries are important sources of information to estimate the incidence and prevalence of these events accurately. The clinical presentation of adverse neurological events can be diverse and depend on the specific condition or syndrome involved. Some events, such as cognitive impairment or movement disorders, may develop gradually over time, while others, such as seizures or stroke-like syndrome, may have an acute onset. Common clinical characteristics observed in adverse neurological events include focal neurological deficits, altered consciousness, and changes in sensory perception, motor abnormalities, speech disturbances, and cognitive impairments. The specific clinical features will vary based on the underlying cause and the affected region of the nervous system [5].

Stroke-like syndrome refers to a clinical presentation characterized by transient or permanent neurological deficits that mimic a stroke but are not caused by a vascular occlusion. Stroke-like syndrome can occur in various contexts, including mitochondrial disorders, autoimmune diseases and certain toxic or metabolic conditions. The clinical presentation of stroke-like syndrome can vary widely, with symptoms such as hemiparesis, aphasia, visual field defects, and altered mental status. The duration and reversibility of these deficits may differ depending on the underlying cause and the promptness of intervention. The underlying mechanisms of adverse neurological events and stroke-like syndrome are multifactorial and often depend on the specific condition or syndrome involved. For example, mitochondrial dysfunction and impaired energy metabolism play a crucial role in the pathogenesis of strokelike syndrome associated with mitochondrial disorders. Autoimmune-mediated processes, including inflammation and microvascular dysfunction, contribute to stroke-like syndrome observed in autoimmune disorders. Genetic mutations can disrupt various cellular processes, leading to neurological dysfunction and stroke-like symptoms. Toxic exposures, metabolic disturbances, and medication side effects can also result in adverse neurological events through various mechanisms, such as oxidative stress, excitotoxicity, or disruption of neurotransmitter systems [6].

Conclusion

In specific cases, particular analytic tests like hereditary testing, cerebrospinal liquid examination, or neurophysiological investigations might be important. Treatment and the executives systems shift contingent upon the hidden reason and clinical setting. Now and again, tending to the basic reason or ending the culpable prescription might prompt side effect goal. Other treatment approaches might incorporate steady consideration, suggestive administration, immunosuppressive treatment, or metabolic mediations customized to the particular condition. Unfriendly neurological occasions, including stroke-like disorder, address a different gathering of conditions that can essentially influence patient wellbeing and prosperity. Figuring out the occurrence, clinical attributes, and hidden instruments of these occasions is urgent for precise finding and fitting administration. Further exploration and epidemiological examinations are expected to decide the genuine frequency and predominance of unfavorable neurological occasions, including strokelike disorder, in different populaces. By expanding mindfulness, working on demonstrative methodologies, and fitting administration procedures to the fundamental reason, medical services experts can enhance patient consideration and results for those impacted by antagonistic neurological occasions.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Walsh, Dominic M. and Dennis J. Selkoe. "Deciphering the molecular basis of memory failure in Alzheimer's disease." Neuron 44 (2004): 181-193.

Google Scholar, Crossref, Indexed at

2. Weissman, Lior, Dong-Gyu Jo, Martin M. Sørensen and Nadja C. de Souza-Pinto, et al. "Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment." Nucleic Acids Res 35 (2007): 5545-5555.

Google Scholar, Crossref, Indexed at

3. Petersen, Andrew J., Stacey A. Rimkus and David A. Wassarman. "ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila." Proc Natl Acad Sci 109 (2012): E656-E664.

Google Scholar, Crossref, Indexed at

4. Kuljis, Rodrigo O., Yang Xu, M. Cecilia Aguila and David Baltimore. "Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia–telangiectasia." Proc Natl Acad Sci 94 (1997): 12688-12693.

Google Scholar, Crossref, Indexed at

5. Culmsee, Carsten, Xiaoxiang Zhu, Qian‐Sheng Yu and Sic L. Chan, et al. "A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide." J Neurochem 77 (2001): 220-228.

Google Scholar, Crossref, Indexed at

6. Barthet, Gaël, Ana Moreira-de-Sá, Pei Zhang and Séverine Deforges, et al. "Presenilin and APP regulate synaptic kainate receptors." J Neurosci 42 (2022): 9253-9262.

Google Scholar, Crossref, Indexed at